"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical Care in the FDA Center for Drug Evaluation and Research, said in a news release
And it's not just about womenmale obesity can also affect sperm DNA and increase pregnancy loss risk
Today, Tirzepatide remains a major subject of investigation in metabolic science, endocrinology, obesity research, and cardiometabolic studies
It combines two antidiabetic agents: gliclazide (80 mg) and metformin (500 mg)
Based on what we know today, there isnt yet a clear answer about how long maintenance treatment should last